Gene · 638
Papers2,521
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,521
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancing Patient Care: Innovative Use of Near-Infrared Spectroscopy for Monitoring Urine Volume in Neurogenic Bladder. | Int Neurourol J | 2023 | 37280757 | PubTator, text mining | PubMed |
| Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways. | Int J Mol Sci | 2023 | 37239974 | PubTator, text mining | PubMed |
| Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up. | Arch Rheumatol | 2023 | 37235117 | PubTator, text mining | PubMed |
Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes. | Front Endocrinol (Lausanne) | 2023 | 37223030 | PubTator, text mining | PubMed |
| Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication. | Mol Cancer Ther | 2023 | 37216280 | PubTator, text mining | PubMed |
| Natural flavonols: actions, mechanisms, and potential therapeutic utility for various diseases. | Beni Suef Univ J Basic Appl Sci | 2023 | 37216013 | PubTator, text mining | PubMed |
| Plasmodesmal endoplasmic reticulum proteins regulate intercellular trafficking of cucumber mosaic virus in Arabidopsis. | J Exp Bot | 2023 | 37210666 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy. | Explor Target Antitumor Ther | 2023 | 37205317 | PubTator, text mining | PubMed |
| Correction: Independent role of caspases and Bik in augmenting influenza A virus replication in airway epithelial cells and mice. | Virol J | 2023 | 37189161 | PubTator, text mining | PubMed |
| Design of rigid protein-protein interaction inhibitors enables targeting of undruggable Mcl-1. | Proc Natl Acad Sci U S A | 2023 | 37186857 | PubTator, text mining | PubMed |
| Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases. | Front Oncol | 2023 | 37182123 | PubTator, text mining | PubMed |
| Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner. | Front Pharmacol | 2023 | 37180705 | PubTator, text mining | PubMed |
| Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways. | Cancers (Basel) | 2023 | 37173935 | PubTator, text mining | PubMed |
| The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. | Front Pharmacol | 2023 | 37153758 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| Apoptosis, inflammation, and oxidative stress in infertility: A mini review. | Toxicol Rep | 2023 | 37125147 | PubTator, text mining | PubMed |
| Energy metabolism disturbance in migraine: From a mitochondrial point of view. | Front Physiol | 2023 | 37123270 | PubTator, text mining | PubMed |
| Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis. | Exp Ther Med | 2023 | 37123203 | PubTator, text mining | PubMed |
| Independent role of caspases and Bik in augmenting influenza A virus replication in airway epithelial cells and mice. | Virol J | 2023 | 37095508 | PubTator, text mining | PubMed |
| The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer. | Cancer Genomics Proteomics | 2023 | 37093683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/638/papers?page=9